Archives

by in
Entry Author Date Location
Who Are Biotech’s New Go-To Investment Bankers? 11/12/12 National
Startups Progress with Novel Drugs for Parkinson’s Disease 10/29/12 New York
Betting on Biotech to Catalyze U.S. Job Growth? Don’t Count On It 10/01/12 National
Who Should Life Science Pros Follow on Twitter? 09/24/12 National
Biotech Begins to Come of Age on Twitter 09/17/12 National
Pulmatrix Names Clarke CEO, Releases Promising Data on Lung Drug 09/04/12 Boston
Join Us for BIO Tweetchat at 12:30 pm ET with John Maraganore 06/15/12 National
Who’s on Biotech’s Endangered Species List? Mid-Sized Drugmakers 05/21/12 National
Biotech’s New Frontier: Europe? 03/19/12 National
Amylin, Alkermes Win FDA Approval of Once-Weekly Diabetes Drug 01/27/12 National
The Boston Life Sciences Newsmakers: Civitas, Blend, Forma, & More 01/13/12 Boston
Civitas Charts Positive Data on Inhaled Parkinson’s Drug 01/06/12 Boston
Zogenix Sets Timetable for New Painkiller Drug 12/20/11 San Diego
Infinity, Idera, Civitas, & More Boston-Area Life Sciences Headlines 12/02/11 Boston
Rib-X, Skyhook, Michael J. Fox Foundation & More Boston-Area Deals News 11/30/11 Boston
Alkermes Spinoff, Civitas, Gets Michael J. Fox Support for Inhalable Parkinson’s Drug 11/29/11 Boston
Amylin and Eli Lilly Part Ways on Diabetes Drug; Alkermes Deal Intact 11/08/11 San Diego
T2 Nabs $23M, Ironwood Seeks IBS Drug Approval, FDA Sets Deadline for Alkermes Drug, & More Boston-Area Life Sciences News 08/12/11 Boston
Adventrx Shares Plummet, Pfizer Adds UC San Diego to its Network, New RNAi Center Opens, & More San Diego Life Sciences News 08/11/11 San Diego
Bydureon FDA Deadline Set 08/10/11 San Diego
Amylin & Takeda Halt Obesity Drug Development 08/04/11 San Diego
Vertex Sales Much Bigger Than Expected, Amylin Re-Submits Exenatide, Mini VC Fund Debuts, & More San Diego Life Sciences News 08/04/11 San Diego
Biogen Gets Euro Approval, BSX Shows Solid Q2, Alkermes Tries Again, & More Boston-Area Life Sciences News 07/29/11 Boston
Bydureon Sent Back to FDA 07/28/11 San Diego
Rib-X Inks Sanofi Deal, Zafgen Gets $33M Series C, Allegro Adds $5.4M, & More Boston-Area Life Sciences News 07/08/11 Boston
Amylin, Alkermes Once-Weekly Diabetes Drug Passes Heart Trial Demanded by FDA 07/07/11 San Diego
Alkermes Wins Over Investors With Plan To Become Trans-Atlantic “Big Biotech” 07/06/11 Boston
Inception 1 Raises $5M, VCs Pessimistic About U.S. Biotech Funding, EU Approves Amylin’s Once-a-Week Diabetes Drug, & More San Diego Life Sciences News 06/23/11 San Diego
Amylin, Alkermes Diabetes Med OKd in EU 06/21/11 San Diego
Proteostasis Nabs Partnership, $20M Investment, from Elan To Pursue Neurology Drugs 05/25/11 Boston
Page 2 of 6 « previous page · next page »